Natasha Girgis

Company: Cue Biopharma

Job title: Director, Translational Pharmacology

Seminars:

Navigating the Use of Cytokines to Induce Antigen-Specific Immune Tolerance 11:40 am

• Exploring the use of IL-2 as a specific marker for CD4+ Treg production and its role in assessing ASIT induction • Understanding the broader cytokine landscape and assessing the advantages and disadvantages of using cytokines such as IL-10, TGF-β, and IFN-γ as biomarkers of immune tolerance • Addressing the impact of epitope spreading and…Read more

day: Conference Day One